Skip to main content
. Author manuscript; available in PMC: 2018 May 21.
Published in final edited form as: J Am Acad Dermatol. 2018 Feb;78(2):408–410. doi: 10.1016/j.jaad.2017.07.053

Table I.

Characteristics of lesions treated with very low-dose radiation therapy and standard dose radiation therapy and side effects of treatment

Lesion information VLD-RT (n = 51) SD-RT (n = 37) P value*
Lesion diagnosis, n (%) .1912
 pcMZL 34 (66.7) 17 (48.6)
 pcFCL 17 (33.3) 18 (51.4)
 NOS 0 2 (0.05)
Location, n (%) .5184
 Head 15 (29.4) 17 (46.0)
 Trunk 21 (41.2) 8 (21.6)
 Extremities 15 (29.4) 12 (32.4)
Lesion size (cm) .0145
 N 33 27
 Range 0.2–6.0 0.2–14.0
 Median 1.0 3.0
Duration of follow-up ( years) .0271
 Range 0.02–12.6 0.2–18.8
 Median 3.9 7.0
Immediate side effects, n (%) <.0001
 No 43 (84.3) 8 (21.6)
 Yes
  Erythema 8 (15.7) 5 29 (78.4) 22
  Itch 1 2
  Fatigue 1 2
  PIH 1 0
  Erythema and fatigue 0 1
  Itch and fatigue 0 1
  Pain and fatigue 0 1
Long-term side effects (>6 months), n (%) .0036
 None 47 (92.2) 22 (59.5)
 Yes
  PIH 4 (7.8) 2 15 (40.5) 9
  Hair loss 2 4
  Pain 0 1
  PIH and hair loss 0 1
CR, n (%) .4937
 No
  No response 3 (5.9) 0 1 (2.7) 1
  PR 2 0
  PR with recurrence 1 0
 Yes
  CR 48 (94.1) 39 36 (97.3) 25
  CR with in-field occurrence of new lesions 5 2
  CR with out-of-field occurrence of new lesions 0 8
  CR with relapse of same lesions 4 1

CR, Complete response; NOS, not otherwise specified; pcFCL, primary cutaneous follicle center lymphoma; pcMZL, primary cutaneous marginal zone lymphoma; PIH, postinflammatory hyperpigmentation; PR, partial response; SD-RT, standard dose radiation therapy; VLD-RT, very low-dose radiation therapy.

*

Obtained from generalized repeated measures linear models with the appropriate link function based on the distribution of the lesion characteristic. Continuous measures were transformed when their distributions were skewed.